Inmobiliaria del Sur SA (ISUR)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 17.00 |
|---|---|
| 52-week range | 13.50 – 19.90 |
| Return, 1 month / 3 months | +1.8% / +5.3% |
| Return, 1 year / 3 years | +28.9% / +190.7% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 25.5% |
| Worst drawdown (1 year) | -18.1% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Inmobiliaria del Sur is a Spanish property company based in Seville. It develops residential housing for sale, chiefly apartments and homes in Andalusia, and it also builds and manages commercial and office space. Alongside development, the company holds a portfolio of rental properties and offers related property services to individuals and businesses. Its customers are mainly homebuyers and tenants in southern Spain, together with companies seeking premises.
On this site Inmobiliaria del Sur SA appears as a stock on the Madrid Exchange (Spain), code ISUR, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Inmobiliaria del Sur SA (ISUR) trades on the Madrid Exchange in Spain. It last closed at EUR 17.00 on 22 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 52 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 28.9% and over the last three months it rose 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 4.2% | ||
| From 52-week high | -9.6% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.3% | ||
| 6-month return | 5.0% | ||
| 12-month return, skipping the last month | 26.6% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 25.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.1% | ||
| Liquidity | 52 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.4% |
|---|---|
| 1 month | +1.8% |
| 3 months | +5.3% |
| 6 months | +5.0% |
| 1 year | +28.9% |
| 3 years | +190.7% |
| 5 years | +156.5% |
Signals
| 50-day / 200-day average | 16.78 / 16.32 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.38 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | EUR 0.3159 |
| 13 Jan 2026 | EUR 0.2835 |
| 27 Jun 2025 | EUR 0.2268 |
| 28 Mar 2025 | EUR 0.2800 |
| 9 Jan 2025 | EUR 0.2187 |
| 27 Jun 2024 | EUR 0.1215 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.